How Inflation is Impacting Healthcare

Key Insights:

  • Though it’s not reflected in prices to consumers, the healthcare industry is experiencing inflation.
  • To combat rising prices, practices and hospitals are coming up with alternate solutions to avoid debt.
  • Patients postponing a procedure may offer short-term savings but is bad long-term for the condition.

While patients are feeling the pinch of other increased receipts, according to a recent CNN report, healthcare prices haven’t increased, just yet. The consumer price index, which is captured twelve months at a time and was reported in March, data shows that costs increased on average by 8.5% but healthcare costs only increased by 2%. However, that doesn’t mean that the industry isn’t also feeling the pinch of inflation.

Kevin Stevenson talks about how healthcare is being impacted by inflation. From rising prices of supplies and utilities, across the industry, it is difficult to pass these prices on to the patient. Typically, prices are determined a year at a time. So, the overall costs in the health industry won’t directly reflect these increases.

The industry is having to become resourceful in other terms. For example, operating hours are shifting, services offerings are decreasing, or being suspended. Some hospitals are having to suspend services that just aren’t contributing enough to keep the facilities running and leave the doors open for business. “Just like every other entity, we have to ensure that we’re bringing in more money than we’re spending,” says Stevenson. According to the recent report from CNN, healthcare and medicine’s inflation outpaced other industries at the beginning of the pandemic.

Patients feeling the crunch are canceling and postponing procedures. Unfortunately, Stevenson warns that “while it may be a short term thought to save money in the long term, it’s really not going to. Your condition is going to exacerbate and you’re going to get a lot sicker. Whatever happens down the road is probably going to be more expensive.” Inflation is impacting every industry and every family across the country. From the pump to the grocery store, we’re all feeling it.

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More